Suppr超能文献

聚(ADP - 核糖)聚合酶抑制剂增强美法仑在体内和体外的细胞毒性。

Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly (ADP-ribose) polymerase.

作者信息

Brown D M, Horsman M R, Hirst D G, Brown J M

出版信息

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1665-8. doi: 10.1016/0360-3016(84)90524-8.

Abstract

In these preliminary experiments, we have found enhanced cell killing by the bifunctional alkylating agent L-phenylalanine mustard (L-PAM) in the presence of inhibitors of poly (ADP-ribose) polymerase (ADPRP) in vitro. In vivo enhancement of the tumoricidal effects of L-PAM was observed with the ADPRP inhibitor nicotinamide (1000 mg/kg), although enhanced myelosuppression was also demonstrated. Nicotinamide also increased the plasma elimination half-life of L-PAM by a factor of at least 2. This alteration of L-PAm pharmacokinetics makes it difficult to assess the role that ADPRP inhibition plays in the enhancement of L-PAM tumor cell killing in vivo.

摘要

在这些初步实验中,我们发现,在体外,双功能烷化剂L-苯丙氨酸氮芥(L-PAM)在聚(ADP-核糖)聚合酶(ADPRP)抑制剂存在的情况下,细胞杀伤作用增强。使用ADPRP抑制剂烟酰胺(1000毫克/千克)时,观察到L-PAM的体内杀肿瘤作用增强,尽管也证实有骨髓抑制增强的情况。烟酰胺还使L-PAM的血浆消除半衰期延长至少2倍。L-PAM药代动力学的这种改变使得难以评估ADPRP抑制在体内增强L-PAM对肿瘤细胞杀伤作用中所起的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验